Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
  • 06131/17-9704 oder 9799 (Sekretariat)
  • 06131/17-9669
Publikationen
Ergebnisse pro Seite:  10

Straub, Beate K.; Mueller, Lukas; Duret, Diane S. et al.

Morphomolecular subtyping of hepatocellular adenoma

PATHOLOGIE. 2025 S. 9


Kampitsi, Christina-Evmorfia; Kenborg, Line; Mogensen, Hanna et al.

Mortality after cancer diagnosis among children with congenital heart disease in Denmark and Sweden

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025


Hahn, Marianne; Groeschel, Sonja; Lang, Livia Sophie et al.

Mortality within three months after nonfatal ischemic stroke treated by mechanical thrombectomy in routine care-data from the German Stroke Registry

NEUROLOGICAL RESEARCH AND PRACTICE. Bd. 7. H. 1. 2025


Schmidt, M; Sahin, U

mRNA Vaccination for Breast Cancer

Breast Cancer Immunotherapy. 1. Aufl. Springer 2025


Svensson, Malin; Limeres, Maria Jose; Zeyn, Yanira et al.

mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. Bd. 33. H. 1. 2025


Gambaro, Rocio; Svensson, Malin; Ghazi, Silvia Fraude-El et al.

mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models

MOLECULAR THERAPY. Bd. 33. H. 9. 2025 S. 4156-4174


Barhold, Friederike; Hagemann, Jan; Klimek, Ludger et al.

Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in Germany

RHINOLOGY. Bd. 63. H. 5. 2025


Wansch, Katharina; Pelzer, Uwe; Schneider, Francois et al.

Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids

CANCER CELL INTERNATIONAL. Bd. 25. H. 1. 2025


Wegner, Erik; Buschmann, Victoria; Baranowski, Andreas et al.

Multi-pathway inhibition in the formation of arthrofibrosis: The combination of bosentan and nintedanib

TISSUE ENGINEERING PART A. Bd. 31. H. 11-12. 2025 S. E904-E904